Clinical Experience and Major Learning Points Following the Implementation of the sFlt-1/PlGF Ratio in the Management of Suspected Preeclampsia in a South Australian Tertiary Hospital

( Aust N Z J Obstet Gynaecol . 2025;65(6):860–866. doi: 10.1111/ajo.70046) Understanding of the pathophysiology of preeclampsia (PEC) has progressed rapidly in recent years, particularly with the discovery of an imbalance between placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1). The sFlt-1/PlGF ratio has been shown to be a clinically useful negative predictive marker for the development of PEC; patients with a ratio less than 38 had a negative predictive value of 99.2% for severe PEC. This test was introduced in a local health care network in October of 2021. To date, there is no literature surrounding the implementation of this marker in Australia. This study was a retrospective audit designed to assess how the ratio was ordered and used, provide feedback to clinicians, and provide suggestions for optimization.

Authors

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2026-11-18
DOI
https://doi.org/10.1097/01.aoa.0001288928.29265.43
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Experience and Major Learning Points Following the Implementation of the sFlt-1/PlGF Ratio in the Management of Suspected Preeclampsia in a South Australian Tertiary Hospital

Lu Amy, G Dekker, A Lane, A Parange
Obstetric Anesthesia Digest
Pregnancy and preeclampsia studies
article

Clinical Experience and Major Learning Points Following the Implementation of the sFlt-1/PlGF Ratio in the Management of Suspected Preeclampsia in a South Australian Tertiary Hospital

Lu Amy, G Dekker, A Lane, A Parange
article en

Abstract

( Aust N Z J Obstet Gynaecol . 2025;65(6):860–866. doi: 10.1111/ajo.70046) Understanding of the pathophysiology of preeclampsia (PEC) has progressed rapidly in recent years, particularly with the discovery of an imbalance between placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1). The sFlt-1/PlGF ratio has been shown to be a clinically useful negative predictive marker for the development of PEC; patients with a ratio less than 38 had a negative predictive value of 99.2% for severe PEC. This test was introduced in a local health care network in October of 2021. To date, there is no literature surrounding the implementation of this marker in Australia. This study was a retrospective audit designed to assess how the ratio was ordered and used, provide feedback to clinicians, and provide suggestions for optimization.

Obstetric Anesthesia DigestVol. 46(4)
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon